19.96%SPY 79.52 
5.39%XLF 9.68 3.09%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
SAN DIEGO - Cytori Therapeutics Inc., which develops technology to preserve and develop stem cells, said Monday it will sell one of its stem-cell systems to Astrea International for an undisclosed amount.
| CYTX | 2 |  0 |
Astrea committed to buy one StemCource Cell Bank in Singapore. The system prepares cells to be preserved by freezing.
Astrea also obtained rights from Cytori to sell the system in Malaysia and Brunei. Currently, the system marketed to hospitals in Japan, Korea, Taiwan, and Thailand exclusively by Green Hospital Supply. Cytori sells it directly in Europe, the Middle East and additional countries in Asia.
Shares of Cytori fell 48 cents, or 6.6 percent, to $6.77 in afternoon trading. The stock has traded between $4.62 and $8.56 over the last 52 weeks.
NAME_Timothy F. Geithner AGE-BIRTH DATE-LOCATION-47; August 18, 1961, New York City.
U.S stocks fell on Wednesday as investors grew concerned that a bailout loan package for ailing automakers would fail to be approved by U.S. lawm...
Open auditions on Nov. 23 at the Lyric Theater are meant to find a "young b...
Get your next web design project done with our los angeles web design team - Best web design with great price.
Split Big Profits! You Find it & We Fund it! Co-Own Or Cash Out! Get Free Info Kit Now!
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
